Affordable Access

Publisher Website

Highlights from the Critical Care Canada Forum 2009 - 25 to 28 October 2009, Toronto, Ontario, Canada

Authors
Journal
Critical Care
1364-8535
Publisher
Springer (Biomed Central Ltd.)
Publication Date
Volume
14
Issue
1
Identifiers
DOI: 10.1186/cc8221
Keywords
  • Meeting Report
Disciplines
  • Medicine

Abstract

302-CC8221-Scales.indd Th e Critical Care Canada Forum was held in Toronto, Canada from 25 to 28 October 2009 [1]. Th e conference, which focuses on the care of critically ill patients wherever the patients are located, was attended by 879 delegates and featured 197 separate presentations, includ ing several as yet unpublished trials. Th e hot topic this year was planning for the impact of a worldwide outbreak of H1N1 infl uenza on critical care systems, but the conference also covered a broad range of critical care interventions including mechanical ventilation, sedation and analgesia, renal replacement therapy, and extra- corporeal membrane oxygenation. Herein we summarize just a few of the many exciting clinical trials and plenary topics presented at the conference. H1N1 pandemic Th e Critical Care Canada Forum 2009 featured several presentations describing the outcomes of critically ill patients with H1N1 virus infection from Australia, Mexico, and Canada. Dr Jamie Cooper (Melbourne, Australia), speaking on behalf of the Australia–New Zealand Intensive Care Infl uenza Investigators [2], described outcomes of 722 patients with confi rmed H1N1 virus infection that were admitted to 187 intensive care units. Of these patients, most (92%) were younger than age 65, and large proportions were pregnant (9.1%) or had a body mass index >35 (28.6%). Th e overall mortality rate (as of September 2009) was 14.3% (95% confi dence interval = 11.7 to 16.9%). Nitric oxide, inhaled prostacyclin, and prone positioning were used frequently to treat refractory hypoxemia. Outcomes of 68 patients from 15 centres who were treated with extracorporeal membrane oxygenation were also described [3]. Illness severity was predictably very high in this group, and the overall hospital mortality was 23% with most deaths due to haemorrhage. Dr Anand Kumar (Winnipeg, Canada) and Dr Rob Fowler (Toronto, Canada) presented data from the Canadian Experience [4]. Severe illness due to H1N

There are no comments yet on this publication. Be the first to share your thoughts.